---
figid: PMC8065657__biomolecules-11-00499-g001
figlink: pmc/articles/PMC8065657/figure/biomolecules-11-00499-f001/
number: F1
caption: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/death receptor
  signaling in the regulation of apoptosis and metastasis of cancer cells. (A) Under
  normal apoptotic conditions (e.g., in cancer cells sensitive to TRAIL with activated
  death receptor pathway), TRAIL ligation with its death receptors (DR4 and DR5) or
  an agonistic antibody binding to a corresponding death receptor (DR4 or DR5) on
  the surface of cancer cells induces the formation of the death-inducing signaling
  complex (DISC) involving Fas-associated death domain (FADD) recruitment of pro-caspase-8
  via its death effector domain, resulting in caspase-8 or -10 activation followed
  by cleavage and activation of caspase-3, -6, and -7, and eventual execution of apoptosis
  or anoikis. This mechanism restricts the formation of the metastasis and invasion
  signaling complex (MISC) and subsequently suppresses cell invasion and metastasis.
  When TRAIL/death receptors are inhibited or their functions are compromised, available
  FADD and caspase-8 may recruit and stabilize TNF-receptor-associated factor (TRAF)2
  with the help of S1P, resulting in enhanced TRAF2 polyubiquitination and activation,
  likely through a self-ubiquitination mechanism. This will further lead to activation
  of ERK/JNK/AP-1 signaling and NF-κB activation, which activates MMPs (e.g., MMP1)
  and enhances the release of inflammatory cytokines (e.g., monocyte chemoattractant
  protein 1 (MCP1)) that promote invasion and metastasis of cancer cells. MCP1 may
  induce monocyte chemotactic protein-induced protein-1 (MCPIP1) expression, leading
  to a reduction in DR5 levels, including cell surface DR5; this favors MISC formation
  and metastasis. (B) In TRAIL-insensitive cells, TRAIL treatment will induce the
  formation of a second signaling complex or FADDosome, resulting in the activation
  of multiple protein kinases such as NF-κB, JNK, p38, ERK, and Src that are involved
  in the positive regulation of invasion and metastasis of cancer cells. In KRAS-mutated
  cancer cells, TRAIL/DR5 activation can activate the Rac1/PI3K/Akt axis, promoting
  cell invasion and metastasis. RIPK1, receptor-interacting serine/threonine-protein
  kinase 1. DR, death receptor.
pmcid: PMC8065657
papertitle: Regulation of Cancer Metastasis by TRAIL/Death Receptor Signaling.
reftext: You-Take Oh, et al. Biomolecules. 2021 Apr;11(4):499.
pmc_ranked_result_index: '26278'
pathway_score: 0.93376
filename: biomolecules-11-00499-g001.jpg
figtitle: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/death receptor
  signaling in the regulation of apoptosis and metastasis of cancer cells
year: '2021'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8065657__biomolecules-11-00499-g001.html
  '@type': Dataset
  description: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/death
    receptor signaling in the regulation of apoptosis and metastasis of cancer cells.
    (A) Under normal apoptotic conditions (e.g., in cancer cells sensitive to TRAIL
    with activated death receptor pathway), TRAIL ligation with its death receptors
    (DR4 and DR5) or an agonistic antibody binding to a corresponding death receptor
    (DR4 or DR5) on the surface of cancer cells induces the formation of the death-inducing
    signaling complex (DISC) involving Fas-associated death domain (FADD) recruitment
    of pro-caspase-8 via its death effector domain, resulting in caspase-8 or -10
    activation followed by cleavage and activation of caspase-3, -6, and -7, and eventual
    execution of apoptosis or anoikis. This mechanism restricts the formation of the
    metastasis and invasion signaling complex (MISC) and subsequently suppresses cell
    invasion and metastasis. When TRAIL/death receptors are inhibited or their functions
    are compromised, available FADD and caspase-8 may recruit and stabilize TNF-receptor-associated
    factor (TRAF)2 with the help of S1P, resulting in enhanced TRAF2 polyubiquitination
    and activation, likely through a self-ubiquitination mechanism. This will further
    lead to activation of ERK/JNK/AP-1 signaling and NF-κB activation, which activates
    MMPs (e.g., MMP1) and enhances the release of inflammatory cytokines (e.g., monocyte
    chemoattractant protein 1 (MCP1)) that promote invasion and metastasis of cancer
    cells. MCP1 may induce monocyte chemotactic protein-induced protein-1 (MCPIP1)
    expression, leading to a reduction in DR5 levels, including cell surface DR5;
    this favors MISC formation and metastasis. (B) In TRAIL-insensitive cells, TRAIL
    treatment will induce the formation of a second signaling complex or FADDosome,
    resulting in the activation of multiple protein kinases such as NF-κB, JNK, p38,
    ERK, and Src that are involved in the positive regulation of invasion and metastasis
    of cancer cells. In KRAS-mutated cancer cells, TRAIL/DR5 activation can activate
    the Rac1/PI3K/Akt axis, promoting cell invasion and metastasis. RIPK1, receptor-interacting
    serine/threonine-protein kinase 1. DR, death receptor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TNFSF10
  - TNFRSF10A
  - TNFRSF21
  - TNFRSF10B
  - RAC1
  - TRAF2
  - MBTPS1
  - MAPK8
  - MAPK9
  - MAPK10
  - PTK2
  - MAPK3
  - MAPK1
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - RIPK1
  - IKBKG
  - FOS
  - FOSB
  - FOSL2
  - JUN
  - JUNB
  - FOSL1
  - JUND
  - IKBKB
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - MMP1
  - CCL2
  - AKT2
  - AKT3
  - AKT1
  - SRC
  - ZC3H12A
  - MAPK14
  - MAPK11
  - MAPK13
  - MAPK12
  - STAT3
  - CASP8
  - FADD
  - SPHK1
  - IKKO IKKB
  - cancer
genes:
- word: TRAIL
  symbol: TRAIL
  source: hgnc_alias_symbol
  hgnc_symbol: TNFSF10
  entrez: '8743'
- word: TRAIL
  symbol: TRAIL
  source: hgnc_alias_symbol
  hgnc_symbol: TNFSF10
  entrez: '8743'
- word: (DR4
  symbol: DR4
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF10A
  entrez: '8797'
- word: DR6)
  symbol: DR6
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF21
  entrez: '27242'
- word: (DR4
  symbol: DR4
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF10A
  entrez: '8797'
- word: DR5)
  symbol: DR5
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF10B
  entrez: '8795'
- word: RAC1
  symbol: RAC1
  source: hgnc_symbol
  hgnc_symbol: RAC1
  entrez: '5879'
- word: TRAF2
  symbol: TRAF2
  source: hgnc_symbol
  hgnc_symbol: TRAF2
  entrez: '7186'
- word: S1P
  symbol: S1P
  source: hgnc_alias_symbol
  hgnc_symbol: MBTPS1
  entrez: '8720'
- word: TRAF2
  symbol: TRAF2
  source: hgnc_symbol
  hgnc_symbol: TRAF2
  entrez: '7186'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: FAK
  symbol: FAK
  source: hgnc_alias_symbol
  hgnc_symbol: PTK2
  entrez: '5747'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: RIPK1
  symbol: RIPK1
  source: hgnc_symbol
  hgnc_symbol: RIPK1
  entrez: '8737'
- word: NEMO
  symbol: NEMO
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: АP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: АP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSB
  entrez: '2354'
- word: АP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL2
  entrez: '2355'
- word: АP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: АP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUNB
  entrez: '3726'
- word: АP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL1
  entrez: '8061'
- word: АP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUND
  entrez: '3727'
- word: IKKB
  symbol: IKKB
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: FAK
  symbol: FAK
  source: hgnc_alias_symbol
  hgnc_symbol: PTK2
  entrez: '5747'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: (MMP1
  symbol: MMP1
  source: hgnc_symbol
  hgnc_symbol: MMP1
  entrez: '4312'
- word: (MCP1
  symbol: MCP1
  source: hgnc_alias_symbol
  hgnc_symbol: CCL2
  entrez: '6347'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: MCPIP1
  symbol: MCPIP1
  source: hgnc_alias_symbol
  hgnc_symbol: ZC3H12A
  entrez: '80149'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: Casp-8
  symbol: Casp-8
  source: hgnc_alias_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: FADD
  symbol: FADD
  source: hgnc_symbol
  hgnc_symbol: FADD
  entrez: '8772'
- word: FADD
  symbol: FADD
  source: hgnc_symbol
  hgnc_symbol: FADD
  entrez: '8772'
- word: Casp-8
  symbol: Casp-8
  source: hgnc_alias_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: FADD
  symbol: FADD
  source: hgnc_symbol
  hgnc_symbol: FADD
  entrez: '8772'
- word: Casp-8
  symbol: Casp-8
  source: hgnc_alias_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: SphK1
  symbol: SPHK1
  source: hgnc_symbol
  hgnc_symbol: SPHK1
  entrez: '8877'
- word: FADD
  symbol: FADD
  source: hgnc_symbol
  hgnc_symbol: FADD
  entrez: '8772'
- word: Casp-8
  symbol: Casp-8
  source: hgnc_alias_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: Casp-8
  symbol: Casp-8
  source: hgnc_alias_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: FADD
  symbol: FADD
  source: hgnc_symbol
  hgnc_symbol: FADD
  entrez: '8772'
- word: FADD
  symbol: FADD
  source: hgnc_symbol
  hgnc_symbol: FADD
  entrez: '8772'
- word: Casp-8
  symbol: Casp-8
  source: hgnc_alias_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: Casp-8
  symbol: Casp-8
  source: hgnc_alias_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: FADD
  symbol: FADD
  source: hgnc_symbol
  hgnc_symbol: FADD
  entrez: '8772'
- word: RIPK1
  symbol: RIPK1
  source: hgnc_symbol
  hgnc_symbol: RIPK1
  entrez: '8737'
chemicals:
- word: IKKO IKKB
  source: ''
  identifier: ''
diseases:
- word: cancer
  source: MESH
  identifier: D009369
figid_alias: PMC8065657__F1
redirect_from: /figures/PMC8065657__F1
figtype: Figure
---
